Stay updated on Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.

Latest updates to the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdministrative updates: Revision: v3.4.2 is added and older notices (v3.4.1) are removed; these changes do not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check22 days agoChange DetectedAdded a site-wide funding status notice directing users to cc.nih.gov and opm.gov, and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check30 days agoChange DetectedAdded UI elements: a Show glossary toggle and a new 'Last Update Submitted that Met QC Criteria' label. Updated footer text to display 'No FEAR Act Data' and 'Revision: v3.4.0'.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision history updated: added v3.3.4 and removed v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded a comprehensive Locations section listing numerous sites across the US and internationally and removed older per-state location groupings. The update updates where the study is conducted and how sites are presented on the page.SummaryDifference1%

- Check93 days agoChange DetectedThe Publications section now explains that publications are automatically filled from PubMed, and the page displays Revision: v3.3.2; the previous PubMed wording and Revision: v3.2.0 have been replaced.SummaryDifference0.1%

Stay in the know with updates to Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.